ストックスクリーナーアプリを入手
3.66
3.17%
-0.12
アフターアワーズ：
3.66
Ironwood Pharmaceuticals Inc (IRWD) 最新ニュース
IRWD (Ironwood Pharmaceuticals) Cash From Discontinued Inve - GuruFocus.com
IRWD (Ironwood Pharmaceuticals) Net Income From Continuing Operations : $-3.1 Mil (TTM As of Sep. 2024) - GuruFocus.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 3.7%Should You Sell? - MarketBeat
Ironwood Pharmaceuticals (IRWD) Stock Dips Amidst Market Volatility - GuruFocus.com
Short Bowel Syndrome Pipeline Trends 2024: Clinical Trials, Analysis of Clinical Trials, Therapies, MOA, ROA, and Developments by DelveInsight | Zealand Pharma, Ironwood Pharma, Hanmi Pharma, Shire - Barchart
Gastroparesis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, and FDA Approvals | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda, Neurogastrx, Inc, PTC Thera - The Globe and Mail
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Stock Position Reduced by Harbor Capital Advisors Inc. - Defense World
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Down -69.69% This Year: What Is Going To Happen Next - Stocks Register
Zacks Research Issues Optimistic Estimate for IRWD Earnings - Defense World
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2 - MSN
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 8.7%What's Next? - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Principal Financial Group Inc. - Defense World
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives $10.40 Consensus PT from Brokerages - Defense World
Ironwood Pharmaceuticals (IRWD) Stock Surges Amid Positive Analy - GuruFocus.com
Ironwood Pharmaceuticals (IRWD) Stock Drops Amid Industry Activi - GuruFocus.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 4.1%Here's Why - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Sees Significant Growth in Short Interest - Defense World
Analysts Set Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Price Target at $10.40 - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Sees Significant Increase in Short Interest - MarketBeat
Geode Capital Management LLC Trims Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
Jane Street Group LLC Boosts Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Acquired by Jane Street Group LLC - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 5%Here's Why - MarketBeat
Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Share Price Boosted 26% But Its Business Prospects Need A Lift Too - Simply Wall St
State Street Corp Has $40.87 Million Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
State Street Corp Purchases 677,024 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
Ironwood Pharmaceuticals shares surge on competitor's woes By Investing.com - Investing.com Canada
Here’s Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD) - Insider Monkey
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Stock Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
Diabetic Gastroparesis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, and FDA Approvals | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharmaceuticals, Ironwood Pharma, Takeda - The Globe and Mail
RBBN: 3 Penny Stocks to Watch for Big Gains in 2025 - StockNews.com
Fmr LLC Has $699,000 Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 4.6%Here's What Happened - MarketBeat
The Manufacturers Life Insurance Company Has $225,000 Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
Ironwood Pharmaceuticals, Inc. Announces CFO Changes, Effective December 18, 2024 - Marketscreener.com
Ironwood Pharmaceuticals' SWOT analysis: apraglutide's promise lifts stock outlook - Investing.com
What is Zacks Research’s Forecast for IRWD FY2026 Earnings? - Defense World
Zacks Research Has Negative Outlook of IRWD FY2026 Earnings - MarketBeat
What Makes Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) One Of The Best Momentum Picks? - Stocks Register
Charles Schwab Investment Management Inc. Buys 364,841 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
XBiotech (NASDAQ:XBIT) vs. Ironwood Pharmaceuticals (NASDAQ:IRWD) Critical Analysis - Defense World
High Growth Tech Stocks In The United States To Watch - Simply Wall St
Ironwood Pharmaceuticals, Inc. Announces Resignation of Sravan K. Emany as Senior Vice President and Chief Operating Officer, Effective December 18, 2024 - Marketscreener.com
216,707 Shares in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Purchased by Weiss Asset Management LP - MarketBeat
Hodges Capital Management Inc. Decreases Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Sets New 12-Month Low – Should You Sell? - Defense World
Ironwood Pharmaceuticals (NASDAQ:IRWD) Sets New 52-Week LowHere's Why - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Ironwood stock hits 52-week low at $3.25 amid market challenges - Investing.com
Ironwood Pharmaceuticals announces executive departure By Investing.com - Investing.com Canada
Ironwood Pharmaceuticals announces executive departure - Investing.com
Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer - GlobeNewswire Inc.
Walleye Capital LLC Grows Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
0.94%
0.08%
大文字化:
|
ボリューム (24 時間):